News
Medical device company Globus Medical (NYSE:GMED) fell short of the market’s revenue expectations in Q1 CY2025, with sales falling 1.4% year on year to $598.1 million. On the other hand, the company’s ...
9d
BUCKSCO.Today on MSNCollegeville Office Buildings Sell to Globus Medical with Staggering Price CutTwo office buildings in Collegeville have sold to Audubon-based Globus Medical for $6.2 million, marking an 81 percent drop ...
Globus Medical, Inc. operates as a medical device company that develops and commercializes healthcare solutions. The firm engages in developing products that promote healing in patients with ...
The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...
Globus Medical (NYSE:GMED – Get Free Report)‘s stock had its “neutral” rating restated by analysts at BTIG Research in a research report issued on Tuesday, Marketbeat Ratings reports.
Globus Medical has a lower P/E than the aggregate P/E of 55.32 of the Health Care Equipment & Supplies industry. Ideally, one might believe that the stock might perform worse than its peers ...
Analysts have expressed concerns over the integration of Nevro Corp., which is expected to be more dilutive to earnings than initially forecasted. Despite the challenges, Globus Medical has maintained ...
Chester County Futures (CCF), in collaboration with Globus Medical, recently provided a transformative learning experience for students eager to explore careers in the STEM field. On Apr. 4, students ...
Additionally, the analyst acknowledged that the performance of Nevro and Emerging Technologies could provide some support to Globus Medical’s Spine business. However, there is a belief that even ...
Thornal was president and CEO of spinal cord stimulation company Nevro from April 2023 until it was acquired by Globus Medical last month for about $250 million. Before that, he was group ...
Across the recent three months, 4 analysts have shared their insights on Globus Medical GMED, expressing a variety of opinions spanning from bullish to bearish. In the table below, you'll find a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results